{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T17:14:49Z","timestamp":1783617289734,"version":"3.55.0"},"reference-count":88,"publisher":"Radcliffe Medical Media Ltd","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018]]},"abstract":"<jats:p>Ventricular tachycardia is a common arrhythmia in patients with structural heart disease and heart failure, and is now seen more frequently as these patients survive longer with modern therapies. In addition, these patients often have multiple comorbidities. While anti-arrhythmic drug therapy, implantable cardioverter-defibrillator implantation and ventricular tachycardia ablation are the mainstay of therapy, well managed by the cardiac electrophysiologist, there are many other facets in the care of these patients, such as heart failure management, treatment of comorbidities and anaesthetic interventions, where the expertise of other specialists is essential for optimal patient care. A coordinated team approach is therefore essential to achieve the best possible outcomes for these complex patients.<\/jats:p>","DOI":"10.15420\/aer.2018.37.2","type":"journal-article","created":{"date-parts":[[2018,12,21]],"date-time":"2018-12-21T07:02:44Z","timestamp":1545375764000},"page":"1","source":"Crossref","is-referenced-by-count":21,"title":["Team Management of the Ventricular Tachycardia Patient"],"prefix":"10.15420","volume":"7","author":[{"given":"Pok Tin","family":"Tang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Duc H","family":"Do","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noel G","family":"Boyle","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Cardiology Department, John Radcliffe Hospital, Oxford, UK","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"UCLA Cardiac Arrhythmia Center, UCLA Health System, David Geffen School of Medicine at UCLA, Los Angeles, California, USA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Cardiology Department, St George\u2019s University Hospital, London, UK","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"UCLA Cardiac Arrhythmia Center, UCLA Health System, David Geffen School of Medicine at UCLA, Los Angeles, California, USA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"6096","reference":[{"key":"ref0","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1093\/europace\/euu194","article-title":"EHRA\/HRS\/APHRS expert consensus on ventricular arrhythmias","volume":"16","author":"Pedersen","year":"2014","unstructured":"1. Pedersen CT, Kay GN, Kalman J, et al. EHRA\/HRS\/APHRS expert consensus on ventricular arrhythmias. Europace 2014;16:1257-83.","journal-title":"Europace"},{"key":"ref1","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1093\/europace\/euw090","article-title":"The role of the Arrhythmia Team, an integrated, multidisciplinary approach to treatment of patients with cardiac arrhythmias: results of the European Heart Association survey","volume":"18","author":"Fumagalli","year":"2016","unstructured":"2. Fumagalli S, Chen J, Dobreanu D, et al. The role of the Arrhythmia Team, an integrated, multidisciplinary approach to treatment of patients with cardiac arrhythmias: results of the European Heart Association survey. Europace 2016;18:623-7.","journal-title":"Europace"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1161\/CIRCULATIONAHA.112.000872","article-title":"Management of ventricular tachycardia in the setting of a dedicated unit for the treatment of complex ventricular arrhythmias","volume":"127","author":"Della Bella","year":"2013","unstructured":"3. Della Bella P, Baratto F, Tsiachris D, et al. Management of ventricular tachycardia in the setting of a dedicated unit for the treatment of complex ventricular arrhythmias. Circulation 2013;127:1359-68.","journal-title":"Circulation"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"23","DOI":"10.15420\/aer.2013.2.1.23","article-title":"Wide complex tachycardia - ventricular tachycardia or not ventricular tachycardia, that remains the question","volume":"2","author":"JB","year":"2013","unstructured":"4. Garner JB, Miller JM. Wide complex tachycardia - ventricular tachycardia or not ventricular tachycardia, that remains the question. Arrhythm Electrophysiol Rev 2013;2:23-9.","journal-title":"Arrhythm Electrophysiol Rev"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.hrthm.2007.09.020","article-title":"New algorithm using only lead aVR for differential diagnosis of wide QRS complex tachycardia","volume":"5","author":"Vereckei","year":"2008","unstructured":"5. Vereckei A, Duray G, Sz\u00e9n\u00e1si G, et al. New algorithm using only lead aVR for differential diagnosis of wide QRS complex tachycardia. Heart Rhythm 2008;5:89-98.","journal-title":"Heart Rhythm"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1016\/j.hrthm.2010.03.001","article-title":"R-wave peak time at DII: a new criterion for differentiating between wide complex QRS tachycardias","volume":"7","author":"Pava","year":"2010","unstructured":"6. Pava LF, Peraf\u00e1n P, Badiel M, et al. R-wave peak time at DII: a new criterion for differentiating between wide complex QRS tachycardias. Heart Rhythm 2010;7:922-6.","journal-title":"Heart Rhythm"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1136\/emermed-2013-202973","article-title":"Antidysrhythmic drug therapy for the termination of stable, monomorphic ventricular tachycardia: a systematic review","volume":"32","author":"deSouza","year":"2015","unstructured":"7. deSouza IS, Martindale JL, Sinert R. Antidysrhythmic drug therapy for the termination of stable, monomorphic ventricular tachycardia: a systematic review. Emerg Med J 2015;32:161-7.","journal-title":"Emerg Med J"},{"key":"ref7","doi-asserted-by":"publisher","unstructured":"8. Ortiz M, Mart\u00edn A, Arribas F, et al. Randomised comparison of intravenous procainamide vs. intravenous amiodarone for the acute treatment of tolerated wide QRS tachycardia: the PROCAMIO study. Eur Heart J 2017;38:1329-35.","DOI":"10.1093\/eurheartj\/ehw230"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1253\/circj.CJ-09-0932","article-title":"Efficacy of procainamide and lidocaine in terminating sustained monomorphic ventricular tachycardia","volume":"74","author":"Komura","year":"2010","unstructured":"9. Komura S, Chinushi M, Furushima H, et al. Efficacy of procainamide and lidocaine in terminating sustained monomorphic ventricular tachycardia. Circ J 2010;74:864-9.","journal-title":"Circ J"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/j.hrthm.2004.12.014","article-title":"Using the twelve-lead electrocardiogram to localize the site of origin of ventricular tachycardia","volume":"2","author":"ME","year":"2005","unstructured":"10. Josephson ME, Callans DJ. Using the twelve-lead electrocardiogram to localize the site of origin of ventricular tachycardia. Heart Rhythm 2005;2:443-446.","journal-title":"Heart Rhythm"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1161\/CIRCIMAGING.111.966085","article-title":"Utility of cardiovascular magnetic resonance in identifying substrate for malignant ventricular arrhythmias","volume":"5","author":"White","year":"2012","unstructured":"11. White JA, Fine NM, Gula L, et al. Utility of cardiovascular magnetic resonance in identifying substrate for malignant ventricular arrhythmias. Circ Cardiovasc Imaging 2012;5:12-20.","journal-title":"Circ Cardiovasc Imaging"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1161\/CIRCIMAGING.113.001293","article-title":"Infarct tissue heterogeneity by contrast-enhanced magnetic resonance imaging is a novel predictor of mortality in patients with chronic coronary artery disease and left ventricular dysfunction","volume":"7","author":"Watanabe","year":"2014","unstructured":"12. Watanabe E, Abbasi SA, Heydari B, et al. Infarct tissue heterogeneity by contrast-enhanced magnetic resonance imaging is a novel predictor of mortality in patients with chronic coronary artery disease and left ventricular dysfunction. Circ Cardiovasc Imaging 2014;7:887-94.","journal-title":"Circ Cardiovasc Imaging"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1016\/j.hrthm.2011.02.029","article-title":"Characterization of myocardial scars: electrophysiological imaging correlates in a porcine infarct model","volume":"8","author":"Nakahara","year":"2011","unstructured":"13. Nakahara S, Vaseghi M, Ramorez R, et al. Characterization of myocardial scars: electrophysiological imaging correlates in a porcine infarct model. Heart Rhythm 2011;8:1060-7.","journal-title":"Heart Rhythm"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1161\/CIRCRESAHA.107.158980","article-title":"Magnetic resonance-based anatomical analysis of scar-related ventricular tachycardia: implications for catheter ablation","volume":"101","author":"Ashikaga","year":"2007","unstructured":"14. Ashikaga H, Sasano T, Dong J, et al. Magnetic resonance-based anatomical analysis of scar-related ventricular tachycardia: implications for catheter ablation. Circ Res 2007;101:939-47.","journal-title":"Circ Res"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"2878","DOI":"10.1161\/CIRCULATIONAHA.107.187256","article-title":"Safety of magnetic resonance imaging in patients with cardiovascular devices: an American Heart Association scientific statement from the Committee on Diagnostic and Interventional Cardiac Catheterization, Council on Clinical Cardiology, and the Council on Cardiovascular Radiology and Intervention: endorsed by the American College of Cardiology Foundation, the North American Society for Cardiac Imaging, and the Society for Cardiovascular Magnetic Resonance","volume":"116","author":"Levine","year":"2007","unstructured":"15. Levine GN, Gomes AS, Arai AE, et al. Safety of magnetic resonance imaging in patients with cardiovascular devices: an American Heart Association scientific statement from the Committee on Diagnostic and Interventional Cardiac Catheterization, Council on Clinical Cardiology, and the Council on Cardiovascular Radiology and Intervention: endorsed by the American College of Cardiology Foundation, the North American Society for Cardiac Imaging, and the Society for Cardiovascular Magnetic Resonance. Circulation 2007;116:2878-91.","journal-title":"Circulation"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1056\/NEJMoa1603265","article-title":"Assessing the risks associated with MRI in patients with a pacemaker or defibrillator","volume":"376","author":"Russo","year":"2017","unstructured":"16. Russo RJ, Costa HS, Silva PD, et al. Assessing the risks associated with MRI in patients with a pacemaker or defibrillator. N Engl J Med 2017;376:755-64.","journal-title":"N Engl J Med"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1093\/europace\/eun021","article-title":"Magnetic resonance imaging in individuals with cardiovascular implantable electronic devices","volume":"10","author":"Roguin","year":"2008","unstructured":"17. Roguin A, Schwitter J, Valhaus C, et al. Magnetic resonance imaging in individuals with cardiovascular implantable electronic devices. Europace 2008;10:336-46.","journal-title":"Europace"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/j.hrthm.2017.10.003","article-title":"Cardiac magnetic resonance imaging using wideband sequences in patients with nonconditional cardiac implanted electronic devices","volume":"15","author":"DH","year":"2018","unstructured":"18. Do DH, Eyvazian V, Bayoneta AJ, et al. Cardiac magnetic resonance imaging using wideband sequences in patients with nonconditional cardiac implanted electronic devices. Heart Rhythm 2018;15:218-25.","journal-title":"Heart Rhythm"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"2488","DOI":"10.1016\/j.hrthm.2015.08.014","article-title":"Incidence of abnormal positron emission tomography in patients with unexplained cardiomyopathy and ventricular arrhythmias: the potential role of occult inflammation in arrhythmogenesis","volume":"12","author":"Tung","year":"2015","unstructured":"19. Tung R, Bauer B, Schelbert H, et al. Incidence of abnormal positron emission tomography in patients with unexplained cardiomyopathy and ventricular arrhythmias: the potential role of occult inflammation in arrhythmogenesis. Heart Rhythm 2015;12:2488-98.","journal-title":"Heart Rhythm"},{"key":"ref19","doi-asserted-by":"publisher","unstructured":"20. The Antiarrhythmics Versus Implantable Defibrillators (AVID) Investigators. A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. N Engl J Med 1997;337:1576-84.","DOI":"10.1056\/NEJM199711273372202"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1161\/01.CIR.102.7.748","article-title":"Randomized comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from cardiac arrest: The Cardiac Arrest Study Hamburg (CASH)","volume":"102","author":"Kuck","year":"2000","unstructured":"21. Kuck KH, Cappato R, Siebels J, R\u00fcppel R. Randomized comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from cardiac arrest: The Cardiac Arrest Study Hamburg (CASH). Circulation 2000;102:748-54.","journal-title":"Circulation"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1161\/01.CIR.101.11.1297","article-title":"Canadian Implantable Defibrillator Study (CIDS): a randomized trial of the implantable cardioverter defibrillator against amiodarone","volume":"101","author":"Connolly","year":"2000","unstructured":"22. Connolly SJ, Gent M, Roberts RS, et al. Canadian Implantable Defibrillator Study (CIDS): a randomized trial of the implantable cardioverter defibrillator against amiodarone. Circulation 2000;101:1297-302.","journal-title":"Circulation"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1161\/hc0502.103330","article-title":"Quality of life in the antiarrhythmics versus implantable defibrillators trial: impact of therapy and influence of adverse symptoms and defibrillator shocks","volume":"105","author":"Schron","year":"2002","unstructured":"23. Schron EB, Exner DV, Yao Q, et al. Quality of life in the antiarrhythmics versus implantable defibrillators trial: impact of therapy and influence of adverse symptoms and defibrillator shocks. Circulation 2002;105:589-94.","journal-title":"Circulation"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"3760","DOI":"10.1161\/01.CIR.0000150390.04704.B7","article-title":"Long-term clinical course of patients after termination of ventricular tachyarrhythmia by an implanted defibrillator","volume":"110","author":"Moss","year":"2004","unstructured":"24. Moss AJ, Greenberg H, Case RB, et al. Long-term clinical course of patients after termination of ventricular tachyarrhythmia by an implanted defibrillator. Circulation 2004;110:3760-5.","journal-title":"Circulation"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1056\/NEJMoa071098","article-title":"Prognostic importance of defibrillator shocks in patients with heart failure","volume":"359","author":"Poole","year":"2008","unstructured":"25. Poole JE, Johnson GW, Hellkamp AS, et al. Prognostic importance of defibrillator shocks in patients with heart failure. N Engl J Med 2008;359:1009-17.","journal-title":"N Engl J Med"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"2898","DOI":"10.1161\/CIRCULATIONAHA.104.526673","article-title":"Appropriate and inappropriate ventricular therapies, quality of life, and mortality among primary and secondary prevention implantable cardioverter defibrillator patients: results from the Pacing Fast VT REduces Shock ThErapies (PainFREE Rx II) Trial","volume":"111","author":"Sweeney","year":"2005","unstructured":"26. Sweeney MO, Wathen MS, Volosin K, et al. Appropriate and inappropriate ventricular therapies, quality of life, and mortality among primary and secondary prevention implantable cardioverter defibrillator patients: results from the Pacing Fast VT REduces Shock ThErapies (PainFREE Rx II) Trial. Circulation 2005;111:2898-905.","journal-title":"Circulation"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"2275","DOI":"10.1056\/NEJMoa1211107","article-title":"Reduction in inappropriate therapy and mortality through ICD programming","volume":"367","author":"Moss","year":"2012","unstructured":"27. Moss AJ, Schuger C, Beck CA, et al. Reduction in inappropriate therapy and mortality through ICD programming. N Engl J Med 2012;367:2275-83.","journal-title":"N Engl J Med"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1016\/j.hrthm.2004.07.017","article-title":"Randomized controlled study of detection enhancements versus rate-only detection to prevent inappropriate therapy in a dual-chamber implantable cardioverter-defibrillator","volume":"1","author":"Dorian","year":"2004","unstructured":"28. Dorian P, Philippon F, Thibault B, et al. Randomized controlled study of detection enhancements versus rate-only detection to prevent inappropriate therapy in a dual-chamber implantable cardioverter-defibrillator. Heart Rhythm 2004;1:540-7.","journal-title":"Heart Rhythm"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"1552","DOI":"10.1016\/j.hrthm.2016.03.004","article-title":"Comparitive effectiveness of antiarrhythmic drugs and catheter ablation for the prevention of recurrent ventricular tachycardia in patients with implantable cardioverter-defibrillators: a systematic review and meta-analysis of randomized contolled trials","volume":"13","author":"Santangeli","year":"2016","unstructured":"29. Santangeli P, Muser D, Maeda S, et al. Comparitive effectiveness of antiarrhythmic drugs and catheter ablation for the prevention of recurrent ventricular tachycardia in patients with implantable cardioverter-defibrillators: a systematic review and meta-analysis of randomized contolled trials. Heart Rhythm 2016;13:1552-9.","journal-title":"Heart Rhythm"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1001\/jama.295.2.165","article-title":"Comparison of beta-blockers, amiodarone plus beta-blockers, or sotalol for prevention of shocks from implantable cardioverter defibrillators: the OPTIC study: a randomised trial","volume":"292","author":"Connolly","year":"2006","unstructured":"30. Connolly SJ, Dorian P, Roberts RS, et al. Comparison of beta-blockers, amiodarone plus beta-blockers, or sotalol for prevention of shocks from implantable cardioverter defibrillators: the OPTIC study: a randomised trial. JAMA 2006;292:165-71.","journal-title":"JAMA"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1097\/FJC.0b013e31829651fe","article-title":"Mexiletine as an adjunctive therapy to amiodarone reduces the frequency of ventricular tachyarrhythmia events in patients with an implantable defibrillator","volume":"62","author":"Gao","year":"2013","unstructured":"31. Gao D, Van Herendael H, Alshengeiti L, et al. Mexiletine as an adjunctive therapy to amiodarone reduces the frequency of ventricular tachyarrhythmia events in patients with an implantable defibrillator. J Cardiovasc Pharmacol 2013;62:199-204.","journal-title":"J Cardiovasc Pharmacol"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"1855","DOI":"10.1056\/NEJM199906173402402","article-title":"Prevention of implantable-defibrillator shocks by treatment with sotalol","volume":"340","author":"Pacifico","year":"1999","unstructured":"32. Pacifico A, Hohnloser SH, Williams JH, et al. Prevention of implantable-defibrillator shocks by treatment with sotalol. N Engl J Med 1999;340:1855-62.","journal-title":"N Engl J Med"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"1600","DOI":"10.1111\/j.1540-8159.2011.03208.x","article-title":"Ranolazine reduces ventricular tachycardia burden and ICD shocks in patients with drug-refractory ICD shocks","volume":"34","author":"Bunch","year":"2011","unstructured":"33. Bunch TJ, Mahapatra S, Murdock D, et al. Ranolazine reduces ventricular tachycardia burden and ICD shocks in patients with drug-refractory ICD shocks. Pacing Clin Electrophysiol 2011;34:1600-6.","journal-title":"Pacing Clin Electrophysiol"},{"key":"ref33","unstructured":"34. Ranolazine Implantable Cardioverter-Defibrillator Trial (RAID). 2018. Available at: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT01215253 (accessed 26 October 2018)."},{"key":"ref34","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1056\/NEJMoa1513614","article-title":"Ventricular tachycardia ablation versus escalation of antiarrhythmic drugs","volume":"375","author":"Sapp","year":"2016","unstructured":"35. Sapp JL, Wells GA, Parkash R, et al. Ventricular tachycardia ablation versus escalation of antiarrhythmic drugs. N Engl J Med 2016;375:111-21.","journal-title":"N Engl J Med"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1056\/NEJMoa043399","article-title":"Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure","volume":"352","author":"Bardy","year":"2005","unstructured":"36. Bardy GH, Lee KL, Mark DB, et al. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 2005;352:225-37.","journal-title":"N Engl J Med"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1016\/S0140-6736(96)09145-3","article-title":"Randomised trial of effect of amiodarone on mortality in patients with left-ventricular dysfunction after recent myocardial infarction: EMIAT","volume":"349","author":"Julian","year":"1997","unstructured":"37. Julian DG, Camm AJ, Frangin G, et al. Randomised trial of effect of amiodarone on mortality in patients with left-ventricular dysfunction after recent myocardial infarction: EMIAT. Lancet 1997;349:667-74.","journal-title":"Lancet"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1016\/S0140-6736(96)08171-8","article-title":"Randomised trial of outcome after myocardial infarction in patients with frequent or repetitive ventricular premature depolarisations: CAMIAT","volume":"349","author":"Cairns","year":"1997","unstructured":"38. Cairns JA, Connolly SJ, Roberts R, et al. Randomised trial of outcome after myocardial infarction in patients with frequent or repetitive ventricular premature depolarisations: CAMIAT. Lancet 1997;349:675-82.","journal-title":"Lancet"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1016\/S0735-1097(83)80337-4","article-title":"Electrode catheter ablation of refractory focal ventricular tachycardia","volume":"2","author":"Hartzler","year":"1983","unstructured":"39. Hartzler GO. Electrode catheter ablation of refractory focal ventricular tachycardia. J Am Coll Cardiol 1983;2:1107-13.","journal-title":"J Am Coll Cardiol"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"2284","DOI":"10.1161\/CIRCULATIONAHA.110.989079","article-title":"Clinician update: catheter ablation of ventricular tachycardia","volume":"123","author":"Tung","year":"2011","unstructured":"40. Tung R, Boyle NG, Shivkumar K. Clinician update: catheter ablation of ventricular tachycardia. Circulation 2011;123:2284-8.","journal-title":"Circulation"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.jacep.2015.04.005","article-title":"Multicenter outcomes for catheter ablation of idiopathic premature ventricular complexes","volume":"1","author":"Latchamsetty","year":"2015","unstructured":"41. Latchamsetty R, Yokokawa M, Morady F, et al. Multicenter outcomes for catheter ablation of idiopathic premature ventricular complexes. J Am Coll Cardiol EP 2015;1:116-23.","journal-title":"J Am Coll Cardiol EP"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"2657","DOI":"10.1056\/NEJMoa065457","article-title":"Prophylactic catheter ablation for the prevention of defibrillator therapy","volume":"357","author":"Reddy","year":"2007","unstructured":"42. Reddy VY, Reynolds MR, Neuzil P, et al. Prophylactic catheter ablation for the prevention of defibrillator therapy. N Engl J Med 2007;357:2657-65.","journal-title":"N Engl J Med"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/S0140-6736(09)61755-4","article-title":"Catheter ablation of stable ventricular tachycardia before defibrillator implantation in patients with coronary heart disease (VTACH): a multicentre randomised controlled trial","volume":"375","author":"Kuck","year":"2010","unstructured":"43. Kuck KH, Schaumann A, Eckhardt L, et al. Catheter ablation of stable ventricular tachycardia before defibrillator implantation in patients with coronary heart disease (VTACH): a multicentre randomised controlled trial. Lancet 2010;375:31-40.","journal-title":"Lancet"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1161\/CIRCULATIONAHA.113.003063","article-title":"Outcomes in catheter ablation of ventricular tachycardia in dilated non-ischemic cardiomyopathy in comparison to ischemic cardiomyopathy: results from the Prospective HEart Centre of LeiPzig VT (HELP-VT) Study","volume":"129","author":"Dinov","year":"2014","unstructured":"44. Dinov B, Fiedler L, Sch\u00f6nbauer R, et al. Outcomes in catheter ablation of ventricular tachycardia in dilated non-ischemic cardiomyopathy in comparison to ischemic cardiomyopathy: results from the Prospective HEart Centre of LeiPzig VT (HELP-VT) Study. Circulation 2014;129:728-36.","journal-title":"Circulation"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"1817","DOI":"10.1016\/j.hrthm.2010.07.032","article-title":"Distribution of late potentials within infarct scars assessed by ultra high-density mapping","volume":"7","author":"Nakahara","year":"2010","unstructured":"45. Nakahara S, Tung R, Ramirez RJ, et al. Distribution of late potentials within infarct scars assessed by ultra high-density mapping. Heart Rhythm 2010;7:1817-24.","journal-title":"Heart Rhythm"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1161\/CIRCEP.111.963066","article-title":"Ablation of ventricular arrhythmias in arrhythmogenic right ventricular dysplasia\/cardiomyopathy: arrhythmia-free survival after endo-epicardial substrate based mapping and ablation","volume":"4","author":"Bai","year":"2011","unstructured":"46. Bai R, Di Biase L, Shivkumar K, et al. Ablation of ventricular arrhythmias in arrhythmogenic right ventricular dysplasia\/cardiomyopathy: arrhythmia-free survival after endo-epicardial substrate based mapping and ablation. Circ Arrhythm Electrophysiol 2011;4:478-85.","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"ref46","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1161\/CIRCEP.115.003562","article-title":"Long-term outcome with catheter ablation of ventricular tachycardia in patients with arrhythmogenic right ventricular cardiomyopathy","volume":"8","author":"Santangeli","year":"2015","unstructured":"47. Santangeli P, Zado ES, Supple GE, et al. Long-term outcome with catheter ablation of ventricular tachycardia in patients with arrhythmogenic right ventricular cardiomyopathy. Circ Arrhythm Electrophysiol 2015;8:1413-21.","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"ref47","doi-asserted-by":"publisher","first-page":"3209","DOI":"10.1161\/CIRCULATIONAHA.104.510503","article-title":"Short- and long-term success of substrate-based mapping and ablation of ventricular tachycardia in arrhythmogenic right ventricular dysplasia","volume":"111","author":"Verma","year":"2005","unstructured":"48. Verma A, Kilicaslan F, Schweikert RA, et al. Short- and long-term success of substrate-based mapping and ablation of ventricular tachycardia in arrhythmogenic right ventricular dysplasia. Circulation 2005;111:3209-16.","journal-title":"Circulation"},{"key":"ref48","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1016\/j.jacc.2007.03.049","article-title":"Long-term efficacy of catheter ablation of ventricular tachycardia in patients with arrhythmogenic right ventricular dysplasia\/cardiomyopathy","volume":"50","author":"Dalal","year":"2007","unstructured":"49. Dalal D, Jain R, Tandri H, et al. Long-term efficacy of catheter ablation of ventricular tachycardia in patients with arrhythmogenic right ventricular dysplasia\/cardiomyopathy. J Am Coll Cardiol 2007;50:432-40.","journal-title":"J Am Coll Cardiol"},{"key":"ref49","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1161\/CIRCEP.111.968677","article-title":"Outcomes of catheter ablation of ventricular tachycardia in arrhythmogenic right ventricular dysplasia\/cardiomyopathy","volume":"5","author":"Philips","year":"2012","unstructured":"50. Philips B, Madhavan S, James C, et al. Outcomes of catheter ablation of ventricular tachycardia in arrhythmogenic right ventricular dysplasia\/cardiomyopathy. Circ Arrhythm Electrophysiol 2012;5:499-505.","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"ref50","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1161\/01.CIR.0000088781.99943.95","article-title":"Mapping and ablation of ventricular fibrillation associated with long-QT and Brugada syndromes","volume":"108","author":"Ha\u00efssaguerre","year":"2003","unstructured":"51. Ha\u00efssaguerre M, Extramiana F, Hocini M, et al. Mapping and ablation of ventricular fibrillation associated with long-QT and Brugada syndromes. Circulation 2003;108:925-8.","journal-title":"Circulation"},{"key":"ref51","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1161\/CIRCULATIONAHA.110.972612","article-title":"Prevention of ventricular fibrillation episodes in Brugada syndrome by catheter ablation over the anterior right ventricular outflow tract epicardium","volume":"123","author":"Nademanee","year":"2011","unstructured":"52. Nademanee K, Veerakul G, Chandanamattha P, et al. Prevention of ventricular fibrillation episodes in Brugada syndrome by catheter ablation over the anterior right ventricular outflow tract epicardium. Circulation 2011;123:1270-9.","journal-title":"Circulation"},{"key":"ref52","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1161\/CIRCEP.114.001953","article-title":"Early referral for ablation of scar-related ventricular tachycardia is associated with improved acute and long-term outcomes: results from the Heart Center of Leipzig Ventricular Tachycardia Registry","volume":"7","author":"Dinov","year":"2014","unstructured":"53. Dinov B, Arya A, Bertagnolli L, et al. Early referral for ablation of scar-related ventricular tachycardia is associated with improved acute and long-term outcomes: results from the Heart Center of Leipzig Ventricular Tachycardia Registry. Circ Arrhythm Electrophysiol 2014;7:1144-51.","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"ref53","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1111\/j.1540-8167.2011.02081.x","article-title":"Ventricular tachycardia ablation remains treatment of last resort in structural heart disease: argument for earlier intervention","volume":"22","author":"Frankel","year":"2011","unstructured":"54. Frankel DS, Mountantonakis SE, Ronbinson MR, et al. Ventricular tachycardia ablation remains treatment of last resort in structural heart disease: argument for earlier intervention. J Cardiovasc Electrophysiol 2011;22:1123-8.","journal-title":"J Cardiovasc Electrophysiol"},{"key":"ref54","doi-asserted-by":"publisher","first-page":"1997","DOI":"10.1016\/j.hrthm.2015.05.036","article-title":"Freedom from recurrent ventricular tachycardia after catheter ablation is associated in improved survival in patients with structural heart disease: an International VT Ablation Center Collaborative Group Study","volume":"12","author":"Tung","year":"2015","unstructured":"55. Tung R, Vaseghi M, Frankel DS, et al. Freedom from recurrent ventricular tachycardia after catheter ablation is associated in improved survival in patients with structural heart disease: an International VT Ablation Center Collaborative Group Study. Heart Rhythm 2015;12:1997-2007.","journal-title":"Heart Rhythm"},{"key":"ref55","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.hrthm.2014.10.004","article-title":"Catheter ablation of scar-based ventricular tachycardia: Relationship of procedure duration to outcomes and hospital mortality","volume":"12","author":"Yu","year":"2015","unstructured":"56. Yu R, Ma S, Tung R, et al. Catheter ablation of scar-based ventricular tachycardia: Relationship of procedure duration to outcomes and hospital mortality. Heart Rhythm 2015;12:86-94.","journal-title":"Heart Rhythm"},{"key":"ref56","doi-asserted-by":"publisher","first-page":"161","DOI":"10.15420\/aer.2014.3.3.161","article-title":"Ventricular tachycardia ablation - the right approach for the right patient","volume":"3","author":"Sadek","year":"2014","unstructured":"57. Sadek MM, Schaller RD, Supple GE, et al. Ventricular tachycardia ablation - the right approach for the right patient. Arrhythm Electrophysiol Rev 2014;3:161-77.","journal-title":"Arrhythm Electrophysiol Rev"},{"key":"ref57","doi-asserted-by":"publisher","first-page":"19","DOI":"10.15420\/aer.2015.4.1.19","article-title":"Contemporary mapping techniques of complex cardiac arrhythmias - identifying and modifying the arrhythmogenic substrate","volume":"4","author":"Koutalas","year":"2015","unstructured":"58. Koutalas E, Rolf S, Dinov B, et al. Contemporary mapping techniques of complex cardiac arrhythmias - identifying and modifying the arrhythmogenic substrate. Arrhythm Electrophysiol Rev 2015;4:19-27.","journal-title":"Arrhythm Electrophysiol Rev"},{"key":"ref58","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.1016\/j.hrthm.2018.02.015","article-title":"Mechanisms and management of refractory ventricular arrhythmias in the age of autonomic modulation","volume":"15","author":"Bradfield","year":"2018","unstructured":"59. Bradfield JS, Ajijola OA, Vaseghi M, et al. Mechanisms and management of refractory ventricular arrhythmias in the age of autonomic modulation. Heart Rhythm 2018;15:1252-60.","journal-title":"Heart Rhythm"},{"key":"ref59","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1016\/j.hrthm.2005.09.004","article-title":"Use of thoracic epidural anaesthesia for management of electrical storm: a case report","volume":"12","author":"Mahajan","year":"2005","unstructured":"60. Mahajan A, Moore J, Cesario DA, et al. Use of thoracic epidural anaesthesia for management of electrical storm: a case report. Heart Rhythm 2005;12:1359-62.","journal-title":"Heart Rhythm"},{"key":"ref60","doi-asserted-by":"publisher","first-page":"2255","DOI":"10.1161\/CIRCULATIONAHA.109.929703","article-title":"Neuraxial modulation for refractory ventricular arrhythmias: value of thoracic epidural anaesthesia and surgical left cardiac sympathetic denervation","volume":"121","author":"Bourke","year":"2010","unstructured":"61. Bourke T, Vaseghi M, Michowitz Y, et al. Neuraxial modulation for refractory ventricular arrhythmias: value of thoracic epidural anaesthesia and surgical left cardiac sympathetic denervation. Circulation 2010;121:2255-62.","journal-title":"Circulation"},{"key":"ref61","doi-asserted-by":"publisher","unstructured":"62. Do DH, Bradfield J, Ajijola OA, et al. Thoracic epidural anesthesia can be effective for the short-term management of ventricular tachycardia storm. J Am Heart Assoc 2017;6:e007080.","DOI":"10.1161\/JAHA.117.007080"},{"key":"ref62","doi-asserted-by":"publisher","first-page":"1460","DOI":"10.1111\/jce.13324","article-title":"Stellate ganglion blockade for the treatment of refractory ventricular arrhythmias: a systematic review and meta-analysis","volume":"28","author":"Fudim","year":"2017","unstructured":"63. Fudim M, Boortz-Marx R, Ganesh A, et al. Stellate ganglion blockade for the treatment of refractory ventricular arrhythmias: a systematic review and meta-analysis. J Cardiovasc Electrophysiol 2017;28:1460-7.","journal-title":"J Cardiovasc Electrophysiol"},{"key":"ref63","doi-asserted-by":"publisher","first-page":"1534","DOI":"10.1016\/j.jacep.2017.07.005","article-title":"Hemodynamic support in ventricular tachycardia ablation: an International VT Ablation Center Collaborative Group Study","volume":"3","author":"Turagam","year":"2017","unstructured":"64. Turagam MK, Vuddanda V, Atkins D, et al. Hemodynamic support in ventricular tachycardia ablation: an International VT Ablation Center Collaborative Group Study. JACC Clin Electrophysiol 2017;3:1534-43.","journal-title":"JACC Clin Electrophysiol"},{"key":"ref64","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1161\/CIRCULATIONAHA.106.686534","article-title":"Catheter ablation for the treatment of electrical storm in patients with implantable cardioverter defibrillators: short- and long-term outcomes in a prospective singe-center study","volume":"117","author":"Carbucicchio","year":"2008","unstructured":"65. Carbucicchio C, Santamaria M, Trevisi N, et al. Catheter ablation for the treatment of electrical storm in patients with implantable cardioverter defibrillators: short- and long-term outcomes in a prospective singe-center study. Circulation 2008;117:462-9.","journal-title":"Circulation"},{"key":"ref65","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.hrthm.2017.08.022","article-title":"Successful ventrifcular tachycardia ablation in patients with electrical storm reduces recurrences and improves survival","volume":"15","author":"Vergara","year":"2018","unstructured":"66. Vergara P, Tung R, Vaseghi M, et al. Successful ventrifcular tachycardia ablation in patients with electrical storm reduces recurrences and improves survival. Heart Rhythm 2018;15:48-55.","journal-title":"Heart Rhythm"},{"key":"ref66","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1161\/CIRCULATIONAHA.115.016336","article-title":"Management of a patient with electrical storm: role of epicardial catheter ablation","volume":"133","author":"Haegeli","year":"2016","unstructured":"67. Haegeli LM, Della Bella P, Brunckhorst CB. Management of a patient with electrical storm: role of epicardial catheter ablation. Circulation 2016;133:672-6.","journal-title":"Circulation"},{"key":"ref67","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1016\/j.ahj.2015.09.008","article-title":"Mortality prediction using a modified Seattle Heart Failure Model may improve patient selection for ventricular tachycardia ablation","volume":"170","author":"Vakil","year":"2015","unstructured":"68. Vakil KP, Roukoz H, Tung R, et al. Mortality prediction using a modified Seattle Heart Failure Model may improve patient selection for ventricular tachycardia ablation. Am Heart J 2015;170:1099-104.","journal-title":"Am Heart J"},{"key":"ref68","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1161\/CIRCEP.114.002155","article-title":"Acute haemodynamic decompensation during catheter ablation of scar-related ventricular tachycardia: incidence, predictors, and impact on mortality","volume":"8","author":"Santangeli","year":"2015","unstructured":"69. Santangeli P, Muser D, Zado ES, et al. Acute haemodynamic decompensation during catheter ablation of scar-related ventricular tachycardia: incidence, predictors, and impact on mortality. Circ Arrhythm Electrophysiol 2015;8:68-75.","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"ref69","doi-asserted-by":"publisher","first-page":"2105","DOI":"10.1016\/j.jacc.2017.02.044","article-title":"Early mortality after catheter ablation of ventricular tachycardia in patients with structural heart disease","volume":"69","author":"Santangeli","year":"2017","unstructured":"70. Santangeli P, Frankel D, Tung R, et al. Early mortality after catheter ablation of ventricular tachycardia in patients with structural heart disease. J Am Coll Cardiol 2017;69:2105-15.","journal-title":"J Am Coll Cardiol"},{"key":"ref70","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/s10840-016-0168-8","article-title":"Outcomes of pre-emptive and rescue use of percutaneous left ventricular assist device in patients with structural heart disease undergoing catheter ablation of ventricular tachycardia","volume":"48","author":"Mathuria","year":"2017","unstructured":"71. Mathuria N, Wu G, Rojas-Delgado F, et al. Outcomes of pre-emptive and rescue use of percutaneous left ventricular assist device in patients with structural heart disease undergoing catheter ablation of ventricular tachycardia. J Interv Card Electrophysiol 2017;48:27-34.","journal-title":"J Interv Card Electrophysiol"},{"key":"ref71","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.hrthm.2017.09.005","article-title":"Outcomes of rescue cardiopulmonary support for periprocedural acute haemodynamic decompensation in patients undergoing catheter ablation of electrical storm","volume":"15","author":"Enriquez","year":"2018","unstructured":"72. Enriquez A, Liang J, Gentile J, et al. Outcomes of rescue cardiopulmonary support for periprocedural acute haemodynamic decompensation in patients undergoing catheter ablation of electrical storm. Heart Rhythm 2018;15:75-80.","journal-title":"Heart Rhythm"},{"key":"ref72","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1093\/europace\/euv010","article-title":"Clinical management of arrhythmias in elderly patients: results of the European Heart Rhythm Association Survey","volume":"17","author":"Chen","year":"2015","unstructured":"73. Chen J, Hocini M, Larsen TB, et al. Clinical management of arrhythmias in elderly patients: results of the European Heart Rhythm Association Survey. Europace 2015;17:314-7.","journal-title":"Europace"},{"key":"ref73","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1016\/j.hrthm.2010.02.019","article-title":"Mortality and safety of catheter ablation for antiarrhythmic drug-refractory ventricular tachycardia in elderly patients with coronary artery disease","volume":"7","author":"Inada","year":"2010","unstructured":"74. Inada K, Roberts-Thomson KC, Seiler J, et al. Mortality and safety of catheter ablation for antiarrhythmic drug-refractory ventricular tachycardia in elderly patients with coronary artery disease. Heart Rhythm 2010;7:740-4.","journal-title":"Heart Rhythm"},{"key":"ref74","doi-asserted-by":"publisher","unstructured":"75. Barra S, Begley D, Heck P, et al. Ablation of ventricular tachycardia in the very elderly patient with cardiomyopathy: how old is too old? Can J Cardiol 2015;31:717-22.","DOI":"10.1016\/j.cjca.2014.12.016"},{"key":"ref75","doi-asserted-by":"crossref","unstructured":"76. Vakil K, Garcia S, Tung R, et al. Ventricular tachycardia ablation in the elderly: an International Ventricular Tachycardia Center Collaborative Group analysis. Circ Arrhythm Electrophysiol 2017;10:e005332","DOI":"10.1161\/CIRCEP.117.005332"},{"key":"ref76","unstructured":"77. Tzou WS, Tung R, Frankel DS, et al. Ventricular tachycardia ablation in severe heart failure: an International Ventricular Tachycardia Ablation Center Collaboration Analysis. Circ Arrhythm Electrophysiol 2017;10:e004494."},{"key":"ref77","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1161\/CIRCEP.111.966283","article-title":"Transcoronary ethanol ablation for recurrent ventricular tachycardia after failed catheter ablation: an update","volume":"4","author":"Tokuda","year":"2011","unstructured":"78. Tokuda M, Sobieszcyzk P, Eisenhauer AC, et al. Transcoronary ethanol ablation for recurrent ventricular tachycardia after failed catheter ablation: an update. Circ Arrhythm Electrophysiol 2011;4:889-6.","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"ref78","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1016\/j.hrthm.2017.11.009","article-title":"Hybrid surgical vs percutaneous access epicardial ventricular tachycardia ablation","volume":"15","author":"Li","year":"2018","unstructured":"79. Li A, Hayase J, Do D, et al. Hybrid surgical vs percutaneous access epicardial ventricular tachycardia ablation. Heart Rhythm 2018;15:512-9.","journal-title":"Heart Rhythm"},{"key":"ref79","doi-asserted-by":"publisher","first-page":"3070","DOI":"10.1016\/j.jacc.2017.04.035","article-title":"Cardiac sympathetic denervation for refractory ventricular arrhythmias","volume":"69","author":"Vaseghi","year":"2017","unstructured":"80. Vaseghi M, Barwad P, Malavassi Corales FJ, et al. Cardiac sympathetic denervation for refractory ventricular arrhythmias. J Am Coll Cardiol 2017;69:3070-80.","journal-title":"J Am Coll Cardiol"},{"key":"ref80","unstructured":"81. Padeletti L, Arnar DO, Boncinelli L, et al. EHRA Expert Consensus Statement on the management of cardiovascular implantable electronic devices in patients nearing end of life or requesting withdrawal of therapy. Europace 2010;12:1480-9. https:\/\/doi.org\/10.1093\/europace\/euq275; PMID: 20675674."},{"key":"ref81","doi-asserted-by":"publisher","first-page":"177","DOI":"10.15420\/aer.2015.4.3.177","article-title":"Long-term outcomes of ventricular tachycardia ablation in different types of structural heart disease","volume":"4","author":"Liang","year":"2015","unstructured":"82. Liang JJ, Santangeli P, Callans DJ. Long-term outcomes of ventricular tachycardia ablation in different types of structural heart disease. Arrhythm Electrophysiol Rev 2015;4:177-83.","journal-title":"Arrhythm Electrophysiol Rev"},{"key":"ref82","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1016\/j.jacc.2015.11.041","article-title":"Long-term success of irrigated radiofrequency catheter ablation of sustained ventricular tachycardia: post-approval THERMOCOOL VT trial","volume":"67","author":"Marchlinski","year":"2016","unstructured":"83. Marchlinski FE, Haffajee CI, Beshai JF, et al. Long-term success of irrigated radiofrequency catheter ablation of sustained ventricular tachycardia: post-approval THERMOCOOL VT trial. J Am Coll Cardiol 2016;67:674-83.","journal-title":"J Am Coll Cardiol"},{"key":"ref83","doi-asserted-by":"publisher","first-page":"2773","DOI":"10.1161\/CIRCULATIONAHA.108.788604","article-title":"Irrigated radiofrequency catheter ablation guided by electroanatomic mapping for recurrent ventricular tachycardia after myocardial infarction: the Multicenter Thermocool Ventricular Tachycaradia Ablation Trial","volume":"118","author":"Stevenson","year":"2008","unstructured":"84. Stevenson WG, Wilber DJ, Natale A, et al. Irrigated radiofrequency catheter ablation guided by electroanatomic mapping for recurrent ventricular tachycardia after myocardial infarction: the Multicenter Thermocool Ventricular Tachycaradia Ablation Trial. Circulation 2008;118:2773-82.","journal-title":"Circulation"},{"key":"ref84","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/S1099-5129(03)00078-3","article-title":"Implantable cardioverter defibrillator recipients: quality of life in recipients with and without ICD shock delivery: a prospective study","volume":"5","author":"Kamphuis","year":"2003","unstructured":"85. Kamphuis HC, de Leeuw JR, Derksen R, et al. Implantable cardioverter defibrillator recipients: quality of life in recipients with and without ICD shock delivery: a prospective study. Europace 2003;5:381-9.","journal-title":"Europace"},{"key":"ref85","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1056\/NEJMoa0706719","article-title":"Quality of life with defibrillator therapy or amiodarone in heart failure","volume":"359","author":"Mark","year":"2008","unstructured":"86. Mark DB, Anstrom KJ, Sun JL, et al. Quality of life with defibrillator therapy or amiodarone in heart failure. N Engl J Med 2008;359:999-1008.","journal-title":"N Engl J Med"},{"key":"ref86","doi-asserted-by":"publisher","unstructured":"87. Tung R, Shivkumar K. Integrated care for management of ventricular arrhythmias: can a specialized unit and catheter ablation improve mortality? Circulation 2013;127:1354-6.","DOI":"10.1161\/CIRCULATIONAHA.113.001775"},{"key":"ref87","doi-asserted-by":"publisher","first-page":"1842","DOI":"10.1016\/j.jacc.2017.01.047","article-title":"Management of ventricular arrhythmias in patients with advanced heart failure","volume":"69","author":"Santangeli","year":"2017","unstructured":"88. Santangeli P, Rame E, Berati E, Marchlinski F. Management of ventricular arrhythmias in patients with advanced heart failure. J Am Coll Cardiol 2017;69:1842-60.","journal-title":"J Am Coll Cardiol"}],"container-title":["Arrhythmia &amp; Electrophysiology Review"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.aerjournal.com\/articles\/Management-Ventricular-Tachycardia","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T16:45:56Z","timestamp":1783615556000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.aerjournal.com\/articleindex\/aer.2018.37.2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018]]},"references-count":88,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018]]}},"alternative-id":["aer.2018.37.2"],"URL":"https:\/\/doi.org\/10.15420\/aer.2018.37.2","relation":{},"ISSN":["2050-3377"],"issn-type":[{"value":"2050-3377","type":"print"}],"subject":[],"published":{"date-parts":[[2018]]}}}